Anti-infection
-
BA1832 HBF-0259Summary: HBF-0259 is a potent and selective inhibitor of hepatitis B virus surface antigen (HBsAg) secretion. - BA1835 AB-836Summary: AB-836 is an orally active coat inhibitor.
- BA1836 AB-423Summary: AB-423 is a coat assembly inhibitor.
- BA1838 TorcitabineSummary: Torcitabine (2'-Deoxy-L-cytidine) is an antivirally active molecule.
- BA1839 FNC-TPSummary: FNC-TP is the intracellular active form of FNC.
- BA1840 InarigivirSummary: Inarigivir (ORI-9020; SB-9000) is a dinucleotide antiviral compound that significantly reduces DNA in transgenic mice expressing hepatitis B virus.
- BA1841 BA-53038BSummary: BA-53038B is a core protein alteration modulator (CpAM) that binds to the HAP pocket and regulates coat assembly.
- BA1842 AlamifovirSummary: Alamifovir (LY582563; MCC-478) is a purine nucleotide analog precursor that shows potent activity against wild-type and lamivudine-resistant hepatitis B virus.
- BA1843 TiviciclovirSummary: An antiviral guanosine analog and a hepatitis B virus inhibitor.
- BA1844 DVR-01Summary: DVR-01 is an inhibitor.